Is ESTA a good stock to buy? We came across a bullish thesis on Establishment Labs Holdings Inc. on Valueinvestorsclub.com by greenshoes93. In this article, we will summarize the bulls’ thesis on ESTA. Establishment Labs Holdings Inc.’s share was trading at $65.47 as of April 27th.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Preserve uses Motiva implants with nesting technique preserving ligament structure reducing invasiveness enabling 35-minute local anesthesia procedures faster recovery and ~30% more visible volume increasing surgeon throughput and utilization. Mia is ultra-minimally invasive system for 1–2 cup enhancements using diamond-shaped implant improving projection and width performed in minutes under local anesthesia expanding TAM and consumer accessibility.
Culture emphasizes rapid innovation cycles with surgeons strong FDA differentiated platform first new PMA since 2013 while incumbents rely on bundling rather than product innovation. New Pfizer-exec CEO improves fragmented distributor network especially ROW enhances China channel access supporting mid-single digit international growth acceleration. Costa Rica free zone yields 0% tax through 2030 with NOLs implying long-term ~5% tax rate boosting cash flow.
Reconstruction market equal size to cosmetic but higher price FDA approval expected 2026–27 with existing off-label Motiva usage already in US hospitals. Modeling $5 EPS 2027 and $9 2028 driven by US share 40–65% OUS mid-single digit growth operating leverage with catalysts including US launch reconstruction approval distributor fixes and China upside supporting rerating to $135 at 15x multiple catalysts aligned ahead of rerating.
Previously, we covered a bullish thesis on AbbVie Inc. (ABBV) by Magnus Ofstad in May 2025, which highlighted strong immunology-led growth, Elahere oncology upside, and acquisition-driven pipeline expansion. ABBV’s stock price has depreciated by approximately 0.54% since our coverage. greenshoes93 shares a similar view but emphasizes ESTAs platform-led medical device innovation, surgical efficiency gains, and Motiva-driven TAM expansion within aesthetic healthcare devices.
Establishment Labs Holdings Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 39 hedge fund portfolios held ESTA at the end of the fourth quarter which was 29 in the previous quarter. While we acknowledge the risk and potential of ESTA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ESTA and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
